These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23470489)

  • 1. Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.
    Yang W; Wang L; Paschen W
    J Biomol Screen; 2013 Jun; 18(5):621-8. PubMed ID: 23470489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
    Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
    Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors targeting the SUMOylation pathway: A patent review 2012‑2015 (Review).
    Zhou Y; Ji C; Cao M; Guo M; Huang W; Ni W; Meng L; Yang H; Wei JF
    Int J Mol Med; 2018 Jan; 41(1):3-12. PubMed ID: 29115401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assays of SUMO protease/isopeptidase activity and function in mammalian cells and tissues.
    Kunz K; Müller S; Mendler L
    Methods Enzymol; 2019; 618():389-410. PubMed ID: 30850061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.
    Liu YY; Kogai T; Schultz JJ; Mody K; Brent GA
    J Biol Chem; 2012 Oct; 287(43):36499-508. PubMed ID: 22930759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology.
    Hughes DJ; Tiede C; Penswick N; Tang AA; Trinh CH; Mandal U; Zajac KZ; Gaule T; Howell G; Edwards TA; Duan J; Feyfant E; McPherson MJ; Tomlinson DC; Whitehouse A
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUSP1 antagonizes formation of highly SUMO2/3-conjugated species.
    Mukhopadhyay D; Ayaydin F; Kolli N; Tan SH; Anan T; Kametaka A; Azuma Y; Wilkinson KD; Dasso M
    J Cell Biol; 2006 Sep; 174(7):939-49. PubMed ID: 17000875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
    Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
    J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S; Udagawa O
    Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.
    Alegre KO; Reverter D
    J Biol Chem; 2011 Oct; 286(41):36142-36151. PubMed ID: 21878624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumo-dependent substrate targeting of the SUMO protease Ulp1.
    Elmore ZC; Donaher M; Matson BC; Murphy H; Westerbeck JW; Kerscher O
    BMC Biol; 2011 Oct; 9():74. PubMed ID: 22034919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO Is a Critical Regulator of Salt Stress Responses in Rice.
    Srivastava AK; Zhang C; Yates G; Bailey M; Brown A; Sadanandom A
    Plant Physiol; 2016 Apr; 170(4):2378-91. PubMed ID: 26869703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
    Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
    Wang L; Wansleeben C; Zhao S; Miao P; Paschen W; Yang W
    EMBO Rep; 2014 Aug; 15(8):878-85. PubMed ID: 24891386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.